The short answer
Myeloma staging does not describe where the cancer sits. CRAB - high calcium, renal problems, anemia, bone damage - decides whether smoldering myeloma has turned active. The R-ISS then uses beta-2-microglobulin, albumin, LDH and FISH chromosome results to place active disease in stage I, II or III.
CRAB stands for high calcium, renal problems, anemia and bone damage, and any one moves smoldering myeloma to active.
Myeloma staging combines blood test results rather than describing where the cancer sits in the body.
R-ISS stage III means beta-2-microglobulin at or above 5.5 mg/L plus high LDH or high-risk chromosome changes.
Stage is a snapshot used for planning and comparison, not a countdown clock for any one person.
On this page
Choose how you want to read this
The whole article, with every detail and caution.
This page is for people who have just been told they have multiple myeloma. It explains how doctors decide whether it needs treatment, how it is staged, and what to ask.
Why staging comes after diagnosis
Once a bone marrow biopsy confirms multiple myeloma, two questions follow. How much disease is present? How is it likely to behave? Staging helps answer both. It does not describe where the cancer is, the way staging does for a tumor like breast or lung cancer. Instead, it combines blood test results to estimate how much myeloma is in your body and how aggressive it may be.
The CRAB criteria: from "smoldering" to "active"
Doctors first decide whether myeloma is active enough to need treatment now. They look for four types of organ damage. Doctors remember them with the letters CRAB: high Calcium in the blood, Renal (kidney) problems, Anemia (low red blood cells), and Bone damage, such as fractures or lesions on imaging. Finding one or more of these moves someone from "smoldering myeloma" into "active myeloma." Certain high-risk lab markers can do the same, even without symptoms. Smoldering myeloma is usually watched. Active myeloma is treated.
The Revised International Staging System (R-ISS)
Active myeloma is staged using the R-ISS, which relies on three blood results plus chromosome testing:
- Stage I: Beta-2-microglobulin under 3.5 mg/L, albumin at or above 3.5 g/dL, no high-risk chromosome changes, and normal LDH (a blood enzyme).
- Stage II: Results that fall between stage I and stage III.
- Stage III: Beta-2-microglobulin at or above 5.5 mg/L, combined with either a high LDH level or specific high-risk chromosome changes found on FISH testing.
Beta-2-microglobulin is a protein made by myeloma cells. Higher levels usually mean more disease. Albumin is a protein made by the liver; lower levels can reflect how sick the body is from the disease. Stage is a snapshot used for planning and comparing outcomes across large groups of patients. It is not a countdown clock for any one person.
What staging does and does not decide
NCI says stage at diagnosis is a strong predictor of survival but has little influence on the choice of treatment, because almost everyone with myeloma has disease spread through the marrow. Stage is also used to compare outcomes in research. People at every stage are treated with the goal of controlling the disease. Your chromosome (cytogenetic) results, kidney function, age, and overall fitness all shape the plan alongside the stage number.
What happens after staging
Staging results feed into a first-treatment plan. This commonly combines a targeted drug, an immunotherapy-type drug called a monoclonal antibody, and a steroid. Many people who are fit enough are also considered for a stem cell transplant using their own cells, either soon after diagnosis or later. Ask your team to walk through why a specific combination and timing were chosen for your stage and risk category.
What to ask your team
- Do I meet CRAB criteria, or am I being watched as smoldering myeloma?
- What is my R-ISS stage, and which lab values determined it?
- Are my chromosome (cytogenetic) results standard-risk or high-risk?
- How does my stage affect the treatment being recommended?
- Is a stem cell transplant part of my plan, and if so, when?
When to get help sooner
- Call 911 or go to an emergency department if back pain comes with new weakness in your legs, numbness, or trouble controlling your bladder or bowel. Myeloma weakens the spine, and pressure on the spinal cord has to be relieved fast to protect walking. Do not drive yourself.
- Call 911 or go to an emergency department if you become confused or very drowsy, with heavy thirst, vomiting and weak muscles. That mix points to the high calcium in the C of CRAB, which needs treatment in hospital. Do the same if your temperature reaches 100.4°F (38°C) or higher, since low antibody levels make infection dangerous here and CDC treats fever during cancer treatment as an emergency. Do not drive yourself.
- Call your care team right away if you are passing much less urine than usual, or your ankles and face are puffy. Myeloma can damage the kidneys, the R in CRAB.
- Call your care team right away if a bone starts hurting sharply after a small knock, or tiredness and breathlessness are creeping up on you. These match the B and A of CRAB. For chest pain or trouble breathing, call 911 or go to the ER.
Sources

Common questions
Why does staging work differently in myeloma?
Once a bone marrow biopsy confirms multiple myeloma, staging does not describe where the cancer is, the way it does for a tumor like breast or lung cancer. Instead it combines blood test results to estimate how much myeloma is in your body and how aggressive it may be.
What are the CRAB criteria?
They are the four types of organ damage doctors look for when deciding whether myeloma is active enough to need treatment now: high Calcium in the blood, Renal (kidney) problems, Anemia, and Bone damage such as fractures or lesions on imaging. Finding one or more moves someone from smoldering myeloma into active myeloma, and certain high-risk lab markers can do the same even without symptoms. Smoldering myeloma is usually watched. Active myeloma is treated.
What is the R-ISS?
The Revised International Staging System, used for active myeloma. It relies on three blood results plus chromosome testing. Stage I is beta-2-microglobulin under 3.5 mg/L, albumin at or above 3.5 g/dL, no high-risk chromosome changes and normal LDH. Stage III is beta-2-microglobulin at or above 5.5 mg/L combined with either a high LDH level or specific high-risk chromosome changes found on FISH testing. Stage II is everything that falls in between.
Does my stage decide my treatment?
Not on its own. NCI says stage at diagnosis is a strong predictor of survival but has little influence on the choice of treatment, because almost everyone with myeloma has disease spread through the marrow. People at every stage are treated with the goal of controlling the disease. Your chromosome results, kidney function, age and overall fitness all shape the plan alongside the stage number.
What happens after staging?
Staging results feed into a first-treatment plan, which commonly combines a targeted drug, an immunotherapy-type drug called a monoclonal antibody, and a steroid. Many people who are fit enough are also considered for a stem cell transplant using their own cells, either soon after diagnosis or later. Ask your team to walk through why a specific combination and timing were chosen for your stage and risk category.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Talk with a trained specialist or navigator
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Fever of 100.4°F (38°C) or higher during chemo, severe pain, or trouble breathing: call your cancer care team right away, day or night. Call 911 for an emergency.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Written by: Cancer ExplainedSources last checked: 2026-08-13 what this meansLast updated: 2026-09-29Next planned review: 2027-07-23
Review details and limits
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source checked. This page was written with AI assistance and then compared with the sources listed on it, looking for statements those sources do not back up. That check is not a sentence-by-sentence record and can miss errors. It is not a medical review, and it does not confirm the page is complete or right for your situation.
General education. Low-risk educational or organizational content. Medical facts are cited to authoritative sources.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Words to know
Tap any term to see what it means.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source checked — This page was written with AI assistance and then compared with the sources listed on it, looking for statements those sources do not back up. That check is not a sentence-by-sentence record and can miss errors. It is not a medical review, and it does not confirm the page is complete or right for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
- What Happens When Testing Finds a Targetable Mutation?
- Liquid Biopsy and Circulating Tumor DNA (ctDNA) Explained
- What a PD-L1 Score Means for Immunotherapy
- Inflammatory Breast Cancer: Symptoms & Diagnosis
- Cholangiocarcinoma (Bile Duct Cancer) Guide
- HER2-Positive and HER2-Low Breast Cancer Care
- Uveal Melanoma (Eye Cancer) Diagnosis & Care
- Multiple Myeloma Survival Rates Explained
